Fourrts India

Gastro Division

End to End solution in G.I care

Overview

Fourrts Gastro division was formed in 2013. It was carved out from Premiere division the oldest division of Fourrts.

Launched in 4 Southern states with a field force of 100 Professional Service Representative Gastro division was later was expanded to all India in 2014.

Today, Fourrts Gastro division operates with 285 Professional Services Representatives and a total of 363 field force including line managers.

Fourrts Gastro division is ranked 5th in the Gastro Intestinal therapy Covered market and 29th overall in IPM in G.I. therapy market. Fourrts Gastro division’s Flagship brands Sucrafil & Sucrafil O ranked no. 1 in Sucralfate Therapy in India & across the world.

Purpose of the Division

According to WHO more than 470 million or 39% of Indians suffer from gastrointestinal problems varying from heartburn to constipation and diarrhea. The purpose of Fourrts gastro division is to bridge the therapy gaps in the management of Gastro-intestinal disorders by offering innovative path breaking brands.

Vision of the division

The vision of Fourrts gastro division is to become a leader in Gastro-intestinal therapy in India and the world by offering health care solutions for all gastrointestinal problems benefitting people across all age groups from Children to elderly covering every section of the society by offering innovative, quality products at affordable cost.

Mission of the division

The Mission of Fourrts Gastro division is to be No. 1 in Gastro Covered Market and reach among the top 10 in IPM in G.I. therapy market. To register Rupees 300 crores sales by 2022-23.

Major Therapeutic Categories

Fourrts Gastro division is the only one in the Indian market to offer end to end solutions in GI therapy offering products from Mouth Ulcers to Piles.

Our Therapy offering in Gastroenterology includes:

Luminal Gastroenterology: GERD, Reflux Esophagitis, Gastritis, Duodenal & gastric ulcers, Oral ulcers, Radiation Mucositis, Ulcerative colitis, Crohn’s disease, probiotic therapy for adults & children

Hepato-Pancreato-Biliary diseases: NAFLD, Alcoholic Liver Disease, Viral Hepatitis, Cholestatic Liver Diseases (Gall stones, Cholangitis & Primary Biliary Cirrhosis), Drug Induced Hepatitis, Pancreatic Insufficiency

Functional GI disorders: Functional Dyspepsia, IBS & Functional constipation

Colorectal diseases: Piles, Fissures, Solitary rectal ulcers & Radiation Proctitis

Products

BRAND NAME COMPOSITION
Sucrafil suspension Sucralfate USP 500 mg per 5 ml
Sucrafil O Gel Sucralfate USP 500 mg,  Oxetacaine BP 10 mg per 5 ml
SRFIL Enema Sucralfate USP 2gms rectal suspension
Tocofil Tocotrienol (50%)   200 mg
Udimarin Tab Ursodeoxycholic acid    IP     300mg in betacyclodextrin base
Udimarin Forte SR Ursodeoxycholic Acid I.P- 450mg
PrePro Lactobacillus Acidophilus 200 million + Lactobacillus rhamnosus 100 million + Lactobacillus Casei  100 Million + Lactobacillus bulgaricus 100 Million + Lactobacillus plantarum 100 Million + Bifidobacterium longum 100 Million + Bifidobacterium breve 100 Million + Bifidobacterium infantis 100 Million + Streptococcus thermophilus 100 Million + Fructooligosaccharides 100 mg + Betaglucan 50mg
PrePro IBS Lactobacillus acidophilus  700 Million cfu,  Lactobacillus rhamnosus  600 Million cfu, Lactobacillus Casei  600 Million cfu, Lactobacillus bulgaricus 400 Million cfu, Lactobacillus plantarum 600 Million cfu, Bifidobacterium breve  500 Million cfu, Bifidobacterium longum  500 Million cfu, Bifidobacterium infantis  500 Million cfu, Streptococcus thermophilus  600 Million  cfu, Melatonin 3 mg
PrePro Kid Lactobacillus Acidophilus 650 Millions, Lactobacilus rhamnosus   400 millions, Bifidobacterium Longum  100 Millions, Bifidobacterium infantis  100 Millions, Saccharomyces boulardii 50 million, Elemental Zinc 10 mg, Fructo oligo saccharide  100 mg
PrePro Kid L Lactobacillus Rhamnosus  GG – 5 billion CFU, Saccharomyces boulardii 5 billion CFU
Lanfil Dx Dexlansoprazole IP 60 mg
Lanfil Lansoprazole  IP 15 mg
Laxopeg Polyethylene glycol 3350 – 17gm
Laxopeg FC Polyethylene Glycol  3350  USP  17gm per 50 ml
Laxopeg Kid Polyethylene glycol  3350  USPNF    8.5g
Laxopeg Jar 119/255g Polyethylene glycol 3350 USP 17gm
Oxerute CD Troxerutin  BP   500mg & Citrus Bio flavanoid  500mg
Oxerute Cream Troxerutin 2% w/w, Calcium Dobesilate Monohydrate B.P. 0.25% w/w, Lignocaine Hydrochloride IP 3% w/w, Hydrocortisone Acetate IP 0.25% w/w,    Zinc 5% w/w, Phenylephine Hydrochloride IP 0.1% w/w
Quadrajel Chlorheidine Gluconate Solution     IP, equivalent to Chlorhexidine Gluconate    1% w/w, Metronidazole Benzoate 1% w/w , Lignocaine Hydrochlorede           IP    2%, in Mentholated gel base
Maxizym CAP Pepsin I.P. (1:3000),Diastase I.P (1:1200)
Maxizym Syrup Amylase-20000 DU, Protease-50000 HUT, Glucoamylase -50 AGU, Alpha Galactosidase -225 Galu, Lactase – 1200 ALU, Cellulase – 1250 CU, Lipase – 1000 FIP, Hermicellulase – 1000FIP, Diastase -200 DP, Invertase – 200SU, Papin – 25000FCCPU, Phytase-300PU (Enzymes absorbed Simethicone)
Filoca 5/10 mg Obeticholic Acid 5/10 mg

Notable Achievements

  • Sucrafil O gel was awarded brand of the year by AIOCD AWACS in 2017
  • Sucrafil & Sucrafil O gel together are ranked no.1 in Sucralfate market
  • Sucrafil suspension is ranked among top 300 brands in Nepal
  • Sucrafil & Sucrafil O Gel is registered & market in 14 countries world wide
  • Laxopeg and its SKUs together are ranked no.1 in value in PEG 3350 market
  • Fourrts Gastro division was the first to introduce Pre & Probiotic & Zincbiotic concept in India

Reach Us

044-43441880 (Ext- 217)

gastromktg@fourrts.com